Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of SMOFlipid in Patients Intolerant to Intralipid.

NCT03054948 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03054948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03054948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of SMOFlipid in Patients Intolerant to Intralipid.
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
February 1, 2017
Completion date
March 20, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

home parenteral nutrition, short bowel syndrome